Agoulnik IU - Search Results

1

Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression.

Lopez SM, Agoulnik AI, Zhang M, Peterson LE, Suarez E, Gandarillas GA, Frolov A, Li R, Rajapakshe K, Coarfa C, Ittmann MM, Weigel NL, Agoulnik IU. Lopez SM, et al. Among authors: agoulnik ai, agoulnik iu. Clin Cancer Res. 2016 Aug 1;22(15):3937-49. doi: 10.1158/1078-0432.CCR-15-1983. Epub 2016 Mar 11. Clin Cancer Res. 2016. PMID: 26968201 Free PMC article.

2

A transgenic insertion upstream of sox9 is associated with dominant XX sex reversal in the mouse.

Bishop CE, Whitworth DJ, Qin Y, Agoulnik AI, Agoulnik IU, Harrison WR, Behringer RR, Overbeek PA. Bishop CE, et al. Among authors: agoulnik ai, agoulnik iu. Nat Genet. 2000 Dec;26(4):490-4. doi: 10.1038/82652. Nat Genet. 2000. PMID: 11101852

3

A novel androgen receptor mutant, A748T, exhibits hormone concentration-dependent defects in nuclear accumulation and activity despite normal hormone-binding affinity.

James AJ, Agoulnik IU, Harris JM, Buchanan G, Tilley WD, Marcelli M, Lamb DJ, Weigel NL. James AJ, et al. Among authors: agoulnik iu. Mol Endocrinol. 2002 Dec;16(12):2692-705. doi: 10.1210/me.2001-0281. Mol Endocrinol. 2002. PMID: 12456791

4

Repressors of androgen and progesterone receptor action.

Agoulnik IU, Krause WC, Bingman WE 3rd, Rahman HT, Amrikachi M, Ayala GE, Weigel NL. Agoulnik IU, et al. J Biol Chem. 2003 Aug 15;278(33):31136-48. doi: 10.1074/jbc.M305153200. Epub 2003 May 27. J Biol Chem. 2003. PMID: 12771131 Free article.

5

A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk.

Agoulnik IU, Tong XW, Fischer DC, Körner K, Atkinson NE, Edwards DP, Headon DR, Weigel NL, Kieback DG. Agoulnik IU, et al. J Clin Endocrinol Metab. 2004 Dec;89(12):6340-7. doi: 10.1210/jc.2004-0114. J Clin Endocrinol Metab. 2004. PMID: 15579801

6

Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.

Murthy S, Agoulnik IU, Weigel NL. Murthy S, et al. Among authors: agoulnik iu. Prostate. 2005 Sep 1;64(4):362-72. doi: 10.1002/pros.20251. Prostate. 2005. PMID: 15754350

7

Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer.

Dai H, Li R, Wheeler T, Diaz de Vivar A, Frolov A, Tahir S, Agoulnik I, Thompson T, Rowley D, Ayala G. Dai H, et al. Prostate. 2005 Nov 1;65(3):276-86. doi: 10.1002/pros.20294. Prostate. 2005. PMID: 16015593

8

Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.

Agoulnik IU, Vaid A, Bingman WE 3rd, Erdeme H, Frolov A, Smith CL, Ayala G, Ittmann MM, Weigel NL. Agoulnik IU, et al. Cancer Res. 2005 Sep 1;65(17):7959-67. doi: 10.1158/0008-5472.CAN-04-3541. Cancer Res. 2005. PMID: 16140968

9

The role of relaxin in endometrial cancer.

Kamat AA, Feng S, Agoulnik IU, Kheradmand F, Bogatcheva NV, Coffey D, Sood AK, Agoulnik AI. Kamat AA, et al. Among authors: agoulnik ai, agoulnik iu. Cancer Biol Ther. 2006 Jan;5(1):71-7. doi: 10.4161/cbt.5.1.2289. Epub 2006 Jan 31. Cancer Biol Ther. 2006. PMID: 16322684

10

Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility.

Marcelli M, Stenoien DL, Szafran AT, Simeoni S, Agoulnik IU, Weigel NL, Moran T, Mikic I, Price JH, Mancini MA. Marcelli M, et al. Among authors: agoulnik iu. J Cell Biochem. 2006 Jul 1;98(4):770-88. doi: 10.1002/jcb.20593. J Cell Biochem. 2006. PMID: 16440331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page